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ABSTRACT 
Objective: To develop an innovative prioritisation process to identify topics for new or 
updated systematic reviews of tinnitus research. 
Design: A two stage prioritisation process was devised. Firstly, a scoping review assessed the 
amount of randomised-controlled-trial-level evidence available. This enabled development of 
selection criteria for future reviews, aided the design of template protocol, and suggested the 
scale of work that would be required to conduct these reviews. Secondly, using the pre-
defined primary and secondary criteria, interventions were prioritised for systematic review. 
Study sample: Searches identified 1080 records. After removal of duplicates and out of 
scope works, 437 records remained for full data charting.
Results: The process was tested, using subjective tinnitus as the clinical condition and using 
Cochrane as the systematic review platform. The criteria produced by this process identified 
three high priority reviews: 1) Sound therapy using amplification devices and/or sound 
generators; 2) Betahistine, and 3) Cognitive Behaviour Therapy. Further secondary priorities 
were: 4) Gingko biloba, 5) Anxiolytics, 6) Hypnotics, 7) Antiepileptics, and 8) 
Neuromodulation. 
Conclusions: A process was developed which successfully identified priority areas for 
Cochrane systematic reviews of interventions for subjective tinnitus. This technique could 
easily be transferred to other conditions and other types of systematic reviews.
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1 ABSTRACT 
2 Objective: To develop an innovative prioritisation process to identify topics for new or 
3 updated systematic reviews of tinnitus research. 
4 Design: A two stage prioritisation process was devised. Firstly, a scoping review assessed the 
5 amount of randomised-controlled-trial-level evidence available. This enabled development of 
6 selection criteria for future reviews, aided the design of template protocol, and suggested the 
7 scale of work that would be required to conduct these reviews. Secondly, using the pre-
8 defined primary and secondary criteria, interventions were prioritised for systematic review. 
9 Study sample: Searches identified 1080 records. After removal of duplicates and out of 
10 scope works, 437 records remained for full data charting.
11 Results: The process was tested, using subjective tinnitus as the clinical condition and using 
12 Cochrane as the systematic review platform. The criteria produced by this process identified 
13 three high priority reviews: 1) Sound therapy using amplification devices and/or sound 
14 generators; 2) Betahistine, and 3) Cognitive Behaviour Therapy. Further secondary priorities 
15 were: 4) Gingko biloba, 5) Anxiolytics, 6) Hypnotics, 7) Antiepileptics, and 8) 
16 Neuromodulation. 
17 Conclusions: A process was developed which successfully identified priority areas for 
18 Cochrane systematic reviews of interventions for subjective tinnitus. This technique could 
19 easily be transferred to other conditions and other types of systematic reviews.
20
21
22 Keywords: Cochrane, systematic review, priority, management, treatment, tinnitus
23
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26 Systematic reviews and meta-analyses represent the highest level of evidence for the 
27 effectiveness of clinical interventions and hold a critical place in informing health policy and 
28 evidence-based practice (Greenwell et al.2016; Morata et al., 2017). One of the foremost 
29 organisations producing systematic reviews is Cochrane, which is a UK based charity (not-
30 for-profit organisation) that supervises a global independent network of healthcare 
31 practitioners, researchers, patient advocates and others. It represents more than 11,000 
32 members and over 68,000 supporters from over 130 countries 
33 (https://www.cochrane.org/about-us). Cochrane authors conduct systematic reviews of 
34 health-care interventions and diagnostic tests which are published as Cochrane Reviews in 
35 the Cochrane Library. Previously, Cochrane authors self-selected topics for their reviews and 
36 submitted proposals to Cochrane for approval. This process has been updated and now, 
37 Cochrane groups are encouraged to work strategically to respond to the needs of funders and 
38 key stakeholders to produce reviews on topics of the highest priority to users. One approach 
39 to prioritising these reviews is to conduct a scoping exercise (https://ent.cochrane.org/our-
40 evidence/prioritisation/scoping-projects). Cochrane Ear, Nose, & Throat Disorders (Cochrane 
41 ENT) group this has developed suites of reviews with an “optimal, shared protocol with a 
42 well-designed and consistent set of outcome measures” (Cochrane ENT Group, 2019).   
43 In this report we describe a comprehensive exercise used to prioritise systematic reviews of 
44 interventions for tinnitus conducted for the Cochrane ENT group. 
45 Subjective tinnitus is described as the perception of sound in the absence of an external sound 
46 source (Jastreboff and Hazell, 2004). It is a symptom experienced by 10-30% of the adult 
47 population (McCormack et al., 2016).  About 20% of people with tinnitus experience it as 
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48 bothersome (McCormack et al., 2016). Problems associated with tinnitus include sleep 
49 disturbances, hearing difficulties, difficulties with concentration, social isolation, anxiety, 
50 depression, and emotional difficulties such as irritation or stress (Davis and El Refaie, 2000). 
51 It is estimated that the prevalence of tinnitus in those adults seeking medical help for hearing 
52 problems is as high as 85% (Axelsson and Ringdahl, 1989; Davis and El Refaie, 2000; 
53 Meikle and Taylor-Walsh, 1984). 
54 Tinnitus represents a major financial burden to the healthcare system. For example, in 
55 England there are approximately 0.75 million primary care consultations each year where the 
56 primary complaint is tinnitus (El‐Shunnar et al., 2011) and the average cost to the National 
57 Health System of tinnitus treatment per year is estimated to be GB£750M. The estimated 
58 annual societal costs of tinnitus in the UK is GB£2.7 billion (Stockdale et al., 2017).
59 There is currently no gold standard treatment for tinnitus, rather, various management 
60 strategies are used or have been trialled. Those include education and information, sound-
61 based interventions, psychology-based interventions, self-help interventions, relaxation 
62 therapy, pharmacology-based interventions, manual physical therapy, magnetic stimulation, 
63 electrical stimulation, complementary and alternative therapies, and combination of two or 
64 more approaches (complex interventions). Guidelines for the management of tinnitus have 
65 been developed in the USA and Europe (Cima et al., 2019; Fuller et al., 2017a).  In the UK, 
66 there are commissioning guidelines for tinnitus services for adults (Department of Health, 
67 2009), and clinical practice guidance for the assessment and management of tinnitus in 
68 children (British Society of Audiology, 2015) A Clinical Knowledge Summary has been 
69 produced by the National Institute for Health and Care Excellence (NICE) and two national 
70 guidelines are in development: the first by NICE; the second by the British Society of 
71 Audiology (BSA). NICE has published the scope of the guidelines that are in development 
72 (https://www.nice.org.uk/guidance/gid-ng10077/documents/final-scope) outlining which 
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73 factors will and will not be considered by the guidelines. Effective guidelines can only be 
74 developed if there is strong evidence-based information available. If such high-level evidence 
75 is not available, recommendations arising from the guidelines are weak and clinically 
76 ineffective. These are just some of the drivers for prioritising new and updating existing 
77 Cochrane systematic reviews of interventions for tinnitus.
78
79 METHODS
80 The prioritisation process was conducted in two stages. First, a scoping review was 
81 conducted to estimate the volume of randomised controlled trial (RCT) level evidence 
82 available, to facilitate prioritisation, to aid in the design of a template protocol, and to 
83 estimate the work involved in conducting a suite of priority reviews. Secondly, interventions 
84 were prioritised for review according to a s t of pre-defined criteria. 
85 Scoping review
86 We followed the methodological framework of Arksey and O’Malley (2005). This consisted 
87 of: (1) identifying potentially relevant records; (2) selecting relevant records; (3) extracting 
88 data items; and (4) collating, summarising, and reporting the results. The PRISMA-ScR 
89 checklist (Tricco et al., 2018) guided reporting of the methods and results of the scoping 
90 review.
91 Search strategy
92 In July 2017 we conducted a search of the Cochrane ENT Trials Register (via the Cochrane 
93 Register of studies) for RCTs. There were no language, publication year, or publication status 
94 restrictions. The search was run in the Cochrane ENT Register 
Page 8 of 58
E-mail:editor.ija@up.ac.za  URL: http://mc.manuscriptcentral.com/tija





























































For Peer Review Only
5
Sereda et al. Prioritising topics for systematic review
5
95 (https://ent.cochrane.org/resources/searching-studies/cochrane-ent-trials-register) using the 
96 following strategy:
97 1 MESH DESCRIPTOR Tinnitus EXPLODE ALL AND INREGISTER
98 2 tinnit* AND INREGISTER
99 3 #1 OR #2 AND INREGISTER,
100 where MESH DESCRIPTOR – Medical Subject Headings: The National Library of Medicine 
101 controlled vocabulary thesaurus,  INREGISTER – in the Cochrane ENT register, EXPLODE 
102 ALL – search for selected subject heading (Tinnitus) and all of the subject headings in its 
103 family. 
104 The Cochrane ENT Register is populated using the methods described on the Cochrane ENT 
105 website (https://ent.cochrane.org/resources/searching-studies/cochrane-ent-trials-register).
106 We also searched the Cochrane database of Systematic Reviews for all published reviews and 
107 protocols for Cochrane reviews with ‘tinnitus’ in the title. 
108 Selection of studies
109 Three authors (MS, DJH, DAH) independently screened all abstracts to determine eligibility 
110 for inclusion in the scoping review. Records were carried forward for full screening if at least 
111 one of the authors selected it. We considered multiple articles reporting the same trial 
112 together as a single record. Disagreements were discussed between authors until a consensus 
113 was reached. Records were considered for inclusion according to PICOS (Methley et al., 
114 2014), as follows:
115 Population: Children and/or adults with subjective tinnitus 
116 Intervention: All interventions for subjective tinnitus 
117 Comparator: No intervention (e.g. waiting list), different intervention, placebo
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118 Outcome: Did not form an inclusion criterion 
119 Study design:  Randomised controlled trials only.
120 Data extraction
121 Data were extracted using a bespoke template form designed by the authors (MS and DJH), 
122 piloted on a subset of records, and revised before formal data extraction was undertaken. 
123 PICOS data were extracted (population, intervention, comparator, outcomes, and outcome 
124 measures used, and study design). Two authors independently extracted the data.   
125 For each intervention, we recorded whether there were existing RCTs, the number of RCTs, 
126 and whether those RCTs were included or not in existing Cochrane reviews. In scoping the 
127 literature, drug trials were catalogued (by DMcF) according to the World Health 
128 Organization (WHO) Collaborating Centre for Drug Statistics Methodology Anatomical 
129 Therapeutic Chemical (ATC) Classification System (https://www.whocc.no/atc_ddd_index/). 
130 Methodological assessment of published Cochrane reviews
131 A list of published Cochrane systematic reviews and published Cochrane protocols was 
132 populated. When judging whether an existing Cochrane systematic review required updating 
133 or replacing, we considered the date of the most recent literature search of the review, and 
134 whether ongoing studies were identified in those reviews. Both of these factors were used to 
135 consider whether there was new research that may alter the estimates of effect, the quality of 
136 the overall evidence, or the conclusions drawn in the published review. Other methodological 
137 aspects of the systematic reviews were assessed including (1) whether a Preferred Reporting 
138 Items for Systematic Reviews and Meta-Analyses (PRISMA) diagram was included; (2) 
139 whether the latest risk of bias tool was used; (3) whether a ‘Summary of Findings (SoF)’ 
140 table was included; (4) whether the ‘Grading of Recommendations, Assessment, 
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141 Development and Evaluation’ (GRADE; https://gradepro.org/) tool was used (Schünemann et 
142 al., 2013); (5) whether the assessed outcomes included measures of benefits and harms of the 
143 intervention; and (6) whether the review included all of the methods sections currently 
144 recommended by Cochrane (Higgins and Green, 2011).
145 Prioritisation process
146 Authors of this scoping review were experts in tinnitus (clinical researchers, a psychologist, 
147 ENT surgeon, and an audiologist) or experts in Cochrane systematic review methodology. All 
148 authors took part in agreeing the criteria that were used to prioritise reviews. Firstly a list of 
149 criteria was populated including criteria formulated according to the remit from National 
150 Institute for Health Research (NIHR) with additional criteria proposed by individual authors. 
151 Secondly authors ranked these criteria in order of importance. Based on the ranking, four 
152 primary and four secondary criteria were formulated.  
153 Primary criteria were whether: 
154 1. the intervention was available for tinnitus management within the National Health 
155 Service (NHS) When considering drug treatments for tinnitus, this included drugs 
156 that were used on-licence such as betahistine for Ménière’s disease-associated 
157 tinnitus. It also included drugs used that have been recorded as being used off-
158 licence as a primary tinnitus treatment (Langguth et al., 2009; Hall et al., 2011; 
159 McFerran et al., 2018). It did not include drugs used primarily for treating comorbid 
160 conditions.
161 2. the intervention was included in the NICE document, Guidelines scope. Tinnitus: 
162 assessment and management. (https://www.nice.org.uk/guidance/gid-
163 ng10077/documents/final-scope). This document outlined the proposed contents of the 
164 forthcoming NICE Guideline.
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165 3. there was ‘no recommendation’ or disagreement in recommendations for an 
166 intervention within or between current management guidelines
167 4. existing Cochrane systematic reviews concluded there was a lack of evidence for an 
168 intervention, but additional evidence is now available or if there was no current 
169 Cochrane review.
170 Secondary criteria were whether:
171 5. the intervention was already prioritised by healthcare users and healthcare 
172 practitioners in the James Lind Alliance Priority Setting Partnership for tinnitus as a 
173 ‘top 10’ treatment uncertainty.
174 6. there were sufficient new RCTs for a new or updated review to be meaningful.
175 7. interventions were referred to in the tinnitus research network (TINNET) European 
176 clinical practice guideline.
177 8. there was evidence for variability in clinical practice, within or across countries.
178 All methodological considerations, and importance to key stakeholders were considered 
179 together in prioritising updated and new systematic reviews. For each of the interventions 
180 authors judged how many of the primary and secondary criteria were met. From this a list of 
181 high priority reviews was formulated. 
182
183 RESULTS
184 Summary of existing Cochrane reviews
185 The Cochrane Library contained 10 existing Cochrane reviews on tinnitus: amplification with 
186 hearing aids (Hoare et al., 2014), anticonvulsant drugs (Hoekstra et al., 2011), antidepressant 
187 drugs (Baldo et al., 2012), Cognitive Behavioural Therapy (CBT) (Martinez‐Devesa et al., 
188 2010), Ginkgo biloba (Hilton et al., 2013), hyperbaric oxygen (for idiopathic sudden 
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189 sensorineural hearing loss and tinnitus) (Bennett et al., 2012), repetitive Transcranial 
190 Magnetic Stimulation (rTMS) (Meng et al., 2011), sound therapy (masking) (Hobson et al., 
191 2012), Tinnitus Retraining Therapy (TRT) (Phillips and McFerran, 2010a), and zinc 
192 supplements (Person et al., 2016). A further eight protocols for systematic reviews had been 
193 published. Four were protocols for reviews in progress: CBT (Fuller et al., 2017b), glutamate 
194 receptor antagonists (Imsuwansri et al., 2016), melatonin (Ajayi et al., 2014), and 
195 neuromodulation (desynchronisation) (Hoare et al., 2015). In the review of TRT (Phillips and 
196 McFerran, 2010a), the literature search unearthed a number of studies that purported to be 
197 TRT but on inspection did not adhere to the strict protocol described by the developers of 
198 TRT (Jastreboff and Hazell, 2004). Many of these studies observed the underlying principles 
199 of TRT and its scientific rationale which is generally referred to as the neurophysiological 
200 model of tinnitus (Jastreboff, 1990). The authors of the TRT Cochrane review therefore 
201 proposed to write a separate review of these studies which they described as modified TRT. 
202 After discussion it was decided that a single review of both standard (unmodified) TRT and 
203 modified TRT would be more appropriate and a protocol for a review was published (Phillips 
204 and McFerran, 2010b). However, progress on this new review was suspended at the 
205 suggestion of Cochrane. Methods in this protocol were judged as needing updating. 
206 The other three published protocols (acupuncture (Li et al., 2016), low-level laser therapy 
207 (Peng et al., 2014), and an overview of systematic reviews of interventions (Maldonado 
208 Fernández et al., 2015) were withdrawn before the reviews were conducted or completed. 
209 Eight of the 10 published Cochrane reviews were assessed as having outdated methods by the 
210 Cochrane methodologist (EA). The review of zinc supplementation was judged as up-to-date 
211 and the methods robust (Person et al., 2016). The review of amplification with hearing aids 
212 was judged to have up-to-date methods such that the decision to update would depend on 
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213 whether additional RCTs were identified. The number of records included in each of the 10 
214 Cochrane reviews was between one and eight.   
215 New trials for potential inclusion in Cochrane reviews
216 Scoping searches identified 1080 records (Figure 1). Based on title/abstract screening 731 
217 records were selected for full text screening by at least one author. A further 318 records 
218 were excluded that were duplicates (n=127), out of scope (n=11), not randomised (n=86), 
219 conference abstracts with no results published (n=70), or required translation for which we 
220 did not have the resources (Chinese, Japanese, Swedish, Spanish; n=15). Nine abstracts/full 
221 texts were not available. An additional 24 records were identified from lists of references of 
222 systematic reviews bringing th  total number of records for full text screening and data 
223 charting to 437. Among those, 365 records were identified that were new (not covered in 
224 existing Cochrane reviews) RCTs with published results: PICOS data were extracted from 
225 those records. In addition, 51 unpublished registered randomised trials were identified and 
226 data regarding PICOS and trial status were extracted. 
227
228 *** INSERT FIGURE 1 ABOUT HERE***
229
230 Education and information
231 Eight trials were identified that examined information or education. 
232 Sound-based interventions
233 Forty-three new trials of sound-based interventions were identified. The interventions trialled 
234 included: 1) Amplification only devices (n=8); 2) Sound generator only devices (sometimes 
235 referred to as maskers; n=20); 3) Combination devices (i.e. combined amplification and 
236 sound generators; n=5); 4) Acoustic Coordinated Reset (CR) Neuromodulation (n=3); 5) 
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237 Phase-tailored sound treatment (n=1); 6) Spectrally tailored sound treatment (n=2); and 7) 
238 Auditory training (n=4). 
239 Psychology-based interventions
240 Thirty-nine new trials of psychology-based intervention were identified. Thirty-three of those 
241 trialled CBT interventions and three trialled counselling. For the purpose of this scoping 
242 review we included all studies using cognitive and/or behavioural approaches to treatment. It 
243 is worth noting that there is a published protocol for a revision of the Cochrane review of 
244 CBT for tinnitus (Fuller et al., 2017a). This review will examine all interventions for tinnitus 
245 that include cognitive, and/or behavioural interventions. Those would include Acceptance 
246 and Commitment Therapy (ACT) and Mindfulness-based therapies, described as different 
247 ‘waves’ of CBT.
248 Self-help interventions
249 One trial was identified that examined a self-help intervention, namely an online discussion 
250 forum. 
251 Relaxation therapy
252 Eighteen trials of relaxation therapy were identified including: Neurofeedback/Biofeedback 
253 (n=8); Hypnosis/Hypnotherapy (n=3); 3) Relaxation (n=7). 
254 Pharmacology-based interventions
255 One hundred and fifty-eight new trials of pharmacological interventions for tinnitus were 
256 identified. They were classified in nine different categories based on the WHO ATC system: 
257 1) Alimentary tract and metabolism (n=12); 2) Blood and blood forming organs (n=8); 3) 
258 Cardiovascular system (n=20); 4) Genito-urinary system and sex hormones (n=5); 5) 
259 Musculo-skeletal system (n=3); 6) Nervous system (n=83); 7) Respiratory system (n=1); 8) 
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260 Systemic hormonal preparations, excluding sex hormones and insulins (n=8); and 9) Various 
261 (n=2). Thirteen trials of non-classified (i.e. experimental) medications were also identified. 
262 Manual physical therapy
263 Five trials of manual physical therapy were identified including: 1) Cervical spine treatment 
264 (n=3); 2) Myofascial trigger point deactivation (n=1); and 3) Temporomandibular Joint 
265 Treatment (n=1). 
266 Magnetic stimulation
267 Forty-one trials of magnetic stimulation were identified: 1) Repetitive Transcranial Magnetic 
268 Stimulation (rTMS, n=36), 2) Continuous Theta Burst Stimulation (cTBS, n=2); 3) Deep 
269 Transcranial Magnetic Stimulation (n=1); 4) Electromagnetic Ear Stimulation (n=1); and 5) 
270 Rare-earth magnets placed close to the tympanic membrane (n=1). 
271 Electrical stimulation
272 Twenty-three new trials of electrical stimulation were identified including: 1) Cochlear 
273 implant (n=3); 2) Transcranial Alternating Current Stimulation (tACS; n=1); 3) Transcranial 
274 Direct Current Stimulation (tDCS; n=11); 4) Vagus Nerve Stimulation (VNS; n=3); 5) 
275 Transcutaneous Electrical Nerve Stimulation (TENS; n=2); 6) Ear electrical stimulation via 
276 surface tympanic electrode (n=1); and 7) External electrical stimu ation via mastoid bones 
277 (n=1). According to the published Cochrane protocol of neuromodulation 
278 (desynchronisation) for tinnitus (Hoare et al., 2015), all trials of electrical stimulation for 
279 tinnitus are likely to be included.
280 Complementary and alternative therapies
281 Fifty-six trials of complementary and alternative therapies were identified including: 1) 
282 Acupuncture (n=26); 2) Dietary supplements and herbal remedies (n=10); 3) Laser treatment 
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283 (n=14); 4) Ozone (n=1); 5) Ultrasound (n=2); 6) Vibratory stimulation (n=2); and 7) Virtual 
284 reality (n=1). 
285 Complex interventions
286 Twenty-four trials of complex interventions were identified including: 1) Heidelberg Neuro-
287 Music Therapy (n=2); 2) Perceptual/cognitive training (n=4); 3) Progressive Tinnitus 
288 Management (PTM, n=4); 4) Tinnitus Retraining Therapy (TRT, including modified TRT; 
289 n=9); 5) Combination of psychological approaches with other management strategies (n=3); 
290 6) bimodal treatment involving TRT with EMDR and TRT with CBT (n=1); and 7) a 
291 combination of sound based, educational and integrated medicine therapies (n=1).
292 Priority reviews on tinnitus
293 Three high priority reviews were identified based on the pre-defined priority criteria. Those 
294 were: 1) sound therapy using amplification devices and/or sound generators for tinnitus; 2) 
295 betahistine; 3) CBT. 
296 Sound therapy met the first three primary priority criteria, the existing Cochrane reviews 
297 concluded a lack of evidence of clinical effectiveness (Hoare et al., 2014a, Hobson et al., 
298 2012) and new trials were identified. Our recommendation was that a priority Cochrane 
299 review should include amplification only devices, combination devices (combined 
300 amplification and sound generation), and sound generators. Suggested comparisons for 
301 inclusion were: 1) Amplification only vs waiting-list control, placebo, education/information 
302 only with no device; 2) Combination devices vs waiting-list control, placebo, 
303 education/information only with no device, amplification only, sound generator only; 3) 
304 Sound generator only vs waiting-list control, placebo, education/information only with no 
305 device. Trials that have conditions that explicitly included counselling (such as TRT, PTM, 
306 Neuromonics) should be excluded. Counselling was defined according to Culley and Bond 
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307 (2011) as a process that aims to empower patients to reach decisions and take actions for 
308 themselves. Establishing a therapeutic relationship, clarifying and defining problems, 
309 planning actions, and managing expectations are all key features of the approach. Education 
310 and information giving can be entirely one-way, whereas counselling is about empowerment 
311 and enabling patients to arrive at their own solutions using their own internal resources. 
312 Therefore, unless there were explicit efforts and description of a process towards 
313 empowerment in trial reports, and a trained therapist delivered it, then it was not considered 
314 counselling.Betahistine also met the first three primary priority criteria and there is no 
315 existing Cochrane review. We identified six trials for consideration. Comparisons should 
316 include placebo, no intervention, education and information only.  However, it should be 
317 noted that only three trials include the above comparisons (n=3) and the others would not be 
318 suitable for synthesis. Subgroup analyses with and without Ménière’s disease should also be 
319 considered, but we note that there is an existing Cochrane review on Betahistine for 
320 Ménière’s disease or syndrome which has impact on tinnitus symptom severity as a 
321 secondary outcome (Van Esch et al., 2018). 
322 CBT met the first three primary priority criteria. Although there is an existing Cochrane 
323 review (Martinez-Devesa et al., 2010) it is now outdated and does not include all cognitive, 
324 and/or behavioural interventions (Acceptance and Commitment Therapy (ACT) and 
325 Mindfulness-based therapies, described as different ‘waves’ of CBT).  A Cochrane review 
326 examining all cognitive and behavioural approaches for tinnitus is currently ongoing (Fuller 
327 et al., 2017b). 
328 Further priorities (meeting fewer priority criteria) included: 1) Gingko biloba; 2) anxiolytics; 
329 3) hypnotics; 4) antiepileptics; 5) neuromodulation.
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330 Gingko biloba met the first two primary priority criteria. The existing Cochrane review 
331 concluded a lack of evidence for effectiveness (Hilton et al., 2013) and new trials were 
332 identified. Suggested comparisons include placebo, no intervention, education and 
333 information only. Anxiolytics met the first two primary criteria and there is no existing 
334 Cochrane review. Nine trials have been identified which may be eligible. Suggested 
335 comparisons are placebo, no intervention, education and information only. Hypnotics meets 
336 the first two primary criteria and there is no existing Cochrane review. Eight trials have been 
337 identified which may be eligible for inclusion. Suggested comparisons are placebo, no 
338 intervention, education and information only. Antiepileptics met the first two primary criteria 
339 and there is no existing Cochrane review. Eleven trials have been identified. Suggested 
340 comparisons include placebo, no intervention, education and information only. 
341 Neuromodulation met two primary criteria including being in scope of the NICE guidelines. 
342 However, a Cochrane review of neuromodulation for tinnitus is currently ongoing (Hoare et 




347 This technical report highlights a comprehensive exercise we undertook to prioritise topics of 
348 unmet need for high-quality systematic review in tinnitus management.
349 Importantly, these priority reviews will respond to unanswered questions identified in current 
350 and developing clinical practice guidelines for tinnitus. Three high priority reviews are 
351 recommended: 1) sound therapy using amplification devices and/or sound generators for 
352 tinnitus; 2) betahistine; 3) Cognitive Behaviour Therapy. Further priorities are: 4) Gingko 
353 biloba; 5) anxiolytics; 6) hypnotics; 7) antiepileptics; 8) neuromodulation.
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354 Applying a prioritisation process ensures that resources are invested most effectively in work 
355 that meets the needs of funders and stakeholders and addresses known discrepancies or gaps 
356 in clinical knowledge. This particular prioritisation work focused on UK clinical practice for 
357 tinnitus and therefore the relevant priority criteria, such as availability of the intervention 
358 within the NHS and inclusion in the scope of the NICE tinnitus guideline. However, the 
359 process can easily be adapted to a range of international, national or local settings and 
360 priorities. For example, regional or country-specific clinical practice can be taken into 
361 consideration as well as guidelines at the national, regional or international level (e.g. 
362 European or country-specific) when formulating the priority criteria. 
363 The scoping exercise described here has already resulted in the expedited production of two 
364 Cochrane systematic reviews (Sereda et al., 2018; Wegner et al., 2018) in part to inform the 
365 NICE guideline on tinnitus which is currently under development. A further three priority 
366 reviews are currently in progress (Fuller et al., 2017b; Hoare et al. 2015; and Gingko biloba – 
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532 Figure 1. Flow diagram illustrating search strategy and scoping review stages
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534 SUPPLEMENTAL MATERIAL
535 Supplemental material 1. Summary of priority criteria for each of the interventions
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1 ABSTRACT 
2 Objective: To develop an innovative prioritisation process to identify topics for new or 
3 updated systematic reviews of tinnitus and hearing research. 
4 Design: A two stage prioritisation process was devised. Firstly, a scoping review assessed the 
5 amount of randomised-controlled-trial-level evidence available. This enabled development of 
6 selection criteria for future reviews, aided the design of template protocol, and suggested the 
7 scale of work that would be required to conduct these reviews. Secondly, using the pre-
8 defined primary and secondary criteria, interventions were prioritised for systematic review. 
9 Study sample: Searches identified 1080 records. After removal of duplicates and out of 
10 scope works, 437 records remained for full data charting.
11 Results: The process was tested, using subjective tinnitus as the clinical condition and using 
12 Cochrane as the systematic review platform. The criteria produced by this process identified 
13 three high priority reviews: 1) Sound therapy using amplification devices and/or sound 
14 generators; 2) Betahistine, and 3) Cognitive Behaviour Therapy. Further secondary priorities 
15 were: 4) Gingko biloba, 5) Anxiolytics, 6) Hypnotics, 7) Antiepileptics, and 8) 
16 Neuromodulation. 
17 Conclusions: A process was developed which successfully identified priority areas for 
18 Cochrane systematic reviews of interventions for subjective tinnitus. This technique could 
19 easily be transferred to other conditions and other types of systematic reviews.
20
21
22 Keywords: Cochrane, systematic review, priority, management, treatment, tinnitus
23
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26 Systematic reviews and meta-analyses represent the highest level of evidence for the 
27 effectiveness of clinical interventions and hold a critical place in informing health policy and 
28 evidence-based practice (Greenwell et al.2016; Morata et al., 2017). One of the foremost 
29 organisations producing systematic reviews is Cochrane, which is a UK based charity (not-
30 for-profit organisation) that supervises a global independent network of healthcare 
31 practitioners, researchers, patient advocates and others. It represents more than 11,000 
32 members and over 68,000 supporters from over 130 countries 
33 (https://www.cochrane.org/about-us). Cochrane authors conduct systematic reviews of 
34 health-care interventions and diagnostic tests which are published as Cochrane Reviews in 
35 the Cochrane Library. Previously, Cochrane authors self-selected topics for their reviews and 
36 submitted proposals to Cochrane for approval. This process has been updated and now, 
37 Cochrane groups are encouraged to work strategically to respond to the needs of funders and 
38 key stakeholders to produce reviews on topics of the highest priority to users. One approach 
39 to prioritising these reviews is to conduct a scoping exercise (https://ent.cochrane.org/our-
40 evidence/prioritisation/scoping-projects). Cochrane Ear, Nose, & Throat Disorders (Cochrane 
41 ENT) group this has developed suites of reviews with an “optimal, shared protocol with a 
42 well-designed and consistent set of outcome measures” (Cochrane ENT Group, 2019).   
43 In this report we describe a comprehensive exercise used to prioritise systematic reviews of 
44 interventions for tinnitus conducted for the Cochrane ENT group. 
45 Subjective tinnitus is described as the perception of sound in the absence of an external sound 
46 source (Jastreboff and Hazell, 2004). It is a symptom experienced by 10-30% of the adult 
47 population (McCormack et al., 2016).  About 20% of people with tinnitus experience it as 
Page 29 of 58
E-mail:editor.ija@up.ac.za  URL: http://mc.manuscriptcentral.com/tija





























































For Peer Review Only
3
Sereda et al. Prioritising topics for systematic review
3
48 bothersome and negatively affecting quality of life (McCormack et al., 2016). Problems 
49 associated with tinnitus include sleep disturbances, hearing difficulties, difficulties with 
50 concentration, social isolation, anxiety, depression, and emotional difficulties such as 
51 irritation or stress (Davis and El Refaie, 2000). It is estimated that the prevalence of tinnitus 
52 in those adults seeking medical help for hearing problems is as high as 85% (Axelsson and 
53 Ringdahl, 1989; Davis and El Refaie, 2000; Meikle and Taylor-Walsh, 1984). 
54 Tinnitus represents a major financial burden to the healthcare system. For example, in 
55 England there are approximately 0.75 million primary care consultations each year where the 
56 primary complaint is tinnitus (El‐Shunnar et al., 2011) and the average cost to the National 
57 Health System of tinnitus treatment per year is estimated to be GB£750M. The estimated 
58 annual societal costs of tinnitus in the UK is GB£2.7 billion (Stockdale et al., 2017).
59 There is currently no gold standard treatment for tinnitus, rather, various management 
60 strategies are used or have been trialled. Those include education and information, sound-
61 based interventions, psychology-based interventions, self-help interventions, relaxation 
62 therapy, pharmacology-based interventions, manual physical therapy, magnetic stimulation, 
63 electrical stimulation, complementary and alternative therapies, and combination of two or 
64 more approaches (complex interventions). Guidelines for the management of tinnitus have 
65 been developed in the USA and Europe (Cima et al., 2019; Fuller et al., 2017a).  In the UK, 
66 there are commissioning guidelines for tinnitus services for adults (Department of Health, 
67 2009), and clinical practice guidance for the assessment and management of tinnitus in 
68 children (British Society of Audiology, 2015) A Clinical Knowledge Summary has been 
69 produced by the National Institute for Health and Care Excellence (NICE) and two national 
70 guidelines are in development: the first by NICE; the second by the British Society of 
71 Audiology (BSA). NICE has published the scope of the guidelines that are in development 
72 (https://www.nice.org.uk/guidance/gid-ng10077/documents/final-scope) outlining which 
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73 factors will and will not be considered by the guidelines. Effective guidelines can only be 
74 developed if there is strong evidence-based information available. If such high-level evidence 
75 is not available, recommendations arising from the guidelines are weak and clinically 
76 ineffective. These are just some of the drivers for prioritising new and updating existing 
77 Cochrane systematic reviews of interventions for tinnitus.
78
79 METHODS
80 The prioritisation process was conducted in two stages. First, a scoping review was 
81 conducted to estimate the volume of randomised controlled trial (RCT) level evidence 
82 available, to facilitate prioritisation, to aid in the design of a template protocol, and to 
83 estimate the work involved in conducting a suite of priority reviews. Secondly, interventions 
84 were prioritised for review according to a s t of pre-defined criteria. 
85 Scoping review
86 We followed the methodological framework of Arksey and O’Malley (2005). This consisted 
87 of: (1) identifying potentially relevant records; (2) selecting relevant records; (3) extracting 
88 data items; and (4) collating, summarising, and reporting the results. The PRISMA-ScR 
89 checklist (Tricco et al., 2018) guided reporting of the methods and results of the scoping 
90 review.
91 Search strategy
92 In July 2017 we conducted a search of the Cochrane ENT Trials Register (via the Cochrane 
93 Register of studies) for RCTs. There were no language, publication year, or publication status 
94 restrictions. The search was run in the Cochrane ENT Register 
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95 (https://ent.cochrane.org/resources/searching-studies/cochrane-ent-trials-register) using the 
96 following strategy:
97 1 MESH DESCRIPTOR Tinnitus EXPLODE ALL AND INREGISTER
98 2 tinnit* AND INREGISTER
99 3 #1 OR #2 AND INREGISTER,
100 where MESH DESCRIPTOR – Medical Subject Headings: The National Library of Medicine 
101 controlled vocabulary thesaurus,  INREGISTER – in the Cochrane ENT register, EXPLODE 
102 ALL – search for selected subject heading (Tinnitus) and all of the subject headings in its 
103 family. 
104 The Cochrane ENT Register is populated using the methods described on the Cochrane ENT 
105 website (https://ent.cochrane.org/resources/searching-studies/cochrane-ent-trials-register).
106 We also searched the Cochrane database of Systematic Reviews for all published reviews and 
107 protocols for Cochrane reviews with ‘tinnitus’ in the title. 
108 Selection of studies
109 Three authors (MS, DJH, DAH) independently screened all abstracts to determine eligibility 
110 for inclusion in the scoping review. Records were carried forward for full screening if at least 
111 one of the authors selected it. We considered multiple articles reporting the same trial 
112 together as a single record. Disagreements were discussed between authors until a consensus 
113 was reached. Records were considered for inclusion according to PICOS (Methley et al., 
114 2014), as follows:
115 Population: Children and/or adults with subjective tinnitus 
116 Intervention: All interventions for subjective tinnitus 
117 Comparator: No intervention (e.g. waiting list), different intervention, placebo
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118 Outcome: Did not form an inclusion criterion 
119 Study design:  Randomised controlled trials only.
120 Data extraction
121 Data were extracted using a bespoke template form designed by the authors (MS and DJH), 
122 piloted on a subset of records, and revised before formal data extraction was undertaken. 
123 PICOS data were extracted (population, intervention, comparator, outcomes, and outcome 
124 measures used, and study design). Two authors independently extracted the data.   
125 For each intervention, we recorded whether there were existing RCTs, the number of RCTs, 
126 and whether those RCTs were included or not in existing Cochrane reviews. In scoping the 
127 literature, drug trials were catalogued (by DMcF) according to the World Health 
128 Organization (WHO) Collaborating Centre for Drug Statistics Methodology Anatomical 
129 Therapeutic Chemical (ATC) Classification System (https://www.whocc.no/atc_ddd_index/). 
130 Methodological assessment of published Cochrane reviews
131 A list of published Cochrane systematic reviews and published Cochrane protocols was 
132 populated. When judging whether an existing Cochrane systematic review required updating 
133 or replacing, we considered the date of the most recent literature search of the review, and 
134 whether ongoing studies were identified in those reviews. Both of these factors were used to 
135 consider whether there was new research that may alter the estimates of effect, the quality of 
136 the overall evidence, or the conclusions drawn in the published review. Other methodological 
137 aspects of the systematic reviews were assessed including (1) whether a Preferred Reporting 
138 Items for Systematic Reviews and Meta-Analyses (PRISMA) diagram was included; (2) 
139 whether the latest risk of bias tool was used; (3) whether a ‘Summary of Findings (SoF)’ 
140 table was included; (4) whether the ‘Grading of Recommendations, Assessment, 
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141 Development and Evaluation’ (GRADE; https://gradepro.org/) tool was used (Schünemann et 
142 al., 2013); (5) whether the assessed outcomes included measures of benefits and harms of the 
143 intervention; and (6) whether the review included all of the methods sections currently 
144 recommended by Cochrane (Higgins and Green, 2011).
145 Prioritisation process
146 Authors of this scoping review were experts in tinnitus (clinical researchers, a psychologist, 
147 ENT surgeon, and an audiologist) or experts in Cochrane systematic review 
148 methodology.Authors of this scoping review were experts in tinnitus, clinical researchers, a 
149 psychologist, ENT surgeon, and an audiologist or experts in Cochrane systematic review 
150 methodology. All authors took part in agreeing the criteria that were used to prioritise 
151 reviews. Firstly a list of criteria was populated including criteria formulated according to the 
152 remit from National Institute for Health Research (NIHR) with additional criteria proposed 
153 by individual authors. Secondly authors ranked these criteria in order of importance. Based 
154 on the ranking, four primary and four secondary criteria were formulated.  
155 Primary criteria were whether: 
156 1. the intervention is was available for tinnitus management within the National Health 
157 Service (NHS) When considering drug treatments for tinnitus, this included drugs 
158 that are were used on-licence such as betahistine for Ménière’s disease-associated 
159 tinnitus. It also included drugs used that have been recorded as being used off-
160 licence as a primary tinnitus treatment (Langguth et al., 2009; Hall et al., 2011; 
161 McFerran et al., 2018). It did not include drugs used primarily for treating comorbid 
162 conditions.
163 2. the intervention is was included in the NICE document, Guidelines scope. Tinnitus: 
164 assessment and management. (https://www.nice.org.uk/guidance/gid-
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165 ng10077/documents/final-scope). This document outlines outlined the proposed 
166 contents of the forthcoming NICE Guideline.
167 3. there was ‘no recommendation’ or disagreement in recommendations for an 
168 intervention within or between current management guidelines
169 4. existing Cochrane systematic reviews concluded there was a lack of evidence for an 
170 intervention, but additional evidence is now available or if there wasis no current 
171 Cochrane review.
172 Secondary criteria were whether:
173 5. the intervention had was already been prioritised by healthcare users and healthcare 
174 practitioners in the James Lind Alliance Priority Setting Partnership for tinnitus as a 
175 ‘top 10’ treatment uncertainty.
176 6. there were sufficient new RCTs for a new or updated review to be meaningful.
177 7. interventions were referred to in the tinnitus research network (TINNET) European 
178 clinical practice guideline.
179 8. there was evidence for variability in clinical practice, within or across countries.
180 All methodological considerations, and importance to key stakeholders were considered 
181 together in prioritising updated and new systematic reviews. For each of the interventions 
182 authors judged how many of the primary and secondary criteria were met. From this a list of 
183 high priority reviews was formulated. 
184
185 RESULTS
186 Summary of existing Cochrane reviews
187 The Cochrane Library contained 10 existing Cochrane reviews on tinnitus: amplification with 
188 hearing aids (Hoare et al., 2014), anticonvulsant drugs (Hoekstra et al., 2011), antidepressant 
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189 drugs (Baldo et al., 2012), Cognitive Behavioural Therapy (CBT) (Martinez‐Devesa et al., 
190 2010), Ginkgo biloba (Hilton et al., 2013), hyperbaric oxygen (for idiopathic sudden 
191 sensorineural hearing loss and tinnitus) (Bennett et al., 2012), repetitive Transcranial 
192 Magnetic Stimulation (rTMS) (Meng et al., 2011), sound therapy (masking) (Hobson et al., 
193 2012), Tinnitus Retraining Therapy (TRT) (Phillips and McFerran, 2010a), and zinc 
194 supplements (Person et al., 2016). A further eight protocols for systematic reviews had been 
195 published. Four were protocols for reviews in progress: CBT (Fuller et al., 2017b), glutamate 
196 receptor antagonists (Imsuwansri et al., 2016), melatonin (Ajayi et al., 2014), and 
197 neuromodulation (desynchronisation) (Hoare et al., 2015). In the review of TRT (Phillips and 
198 McFerran, 2010a), the literatur  search unearthed a number of studies that purported to be 
199 TRT but on inspection did not adhere to the strict protocol described by the developers of 
200 TRT (Jastreboff and Hazell, 2004). Many of these studies observed the underlying principles 
201 of TRT and its scientific rationale which is generally referred to as the neurophysiological 
202 model of tinnitus (Jastreboff, 1990). The authors of the TRT Cochrane review therefore 
203 proposed to write a separate review of these studies which they described as modified TRT. 
204 After discussion it was decided that a single review of both standard (unmodified) TRT and 
205 modified TRT would be more appropriate and a protocol for a review was published (Phillips 
206 and McFerran, 2010b). However, progress on this new review was suspended at the 
207 suggestion of Cochrane. Methods in this protocol were judged as needing updating. The other 
208 three published protocols (acupuncture (Li et al., 2016), low-level laser therapy (Peng et al., 
209 2014), and an overview of systematic reviews of interventions (Maldonado Fernández et al., 
210 2015)) were withdrawn before the reviews were conducted or completed.There were 10 
211 existing Cochrane reviews on tinnitus (Baldo et al., 2012; Bennett et al., 2012; Hilton et al., 
212 2013; Hoare et al., 2014; Hobson et al., 2012; Hoekstra et al., 2011; Martinez‐Devesa et al., 
213 2010; Meng et al., 2011; Person et al., 2016; Phillips and McFerran, 2010a) published in The 
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214 Cochrane Library. The interventions evaluated were Tinnitus Retraining Therapy (TRT), 
215 Cognitive Behavioural Therapy (CBT), anticonvulsants, repetitive Transcranial Magnetic 
216 Stimulation (rTMS), antidepressants, sound therapy (masking), Ginkgo biloba, hyperbaric 
217 oxygen (for idiopathic sudden sensorineural hearing loss and tinnitus), zinc supplements, and 
218 amplification with hearing aids. A further eight protocols for systematic reviews had been 
219 published. Five were protocols for reviews in progress, on neuromodulation 
220 (desynchronisation) (Hoare et al., 2015), neurophysiological model-based treatments (Phillips 
221 and McFerran, 2010b), CBT (Fuller et al., 2017b), glutamate receptor antagonists 
222 (Imsuwansri et al., 2016), and melatonin (Ajayi et al., 2014). The other three published 
223 protocols (acupuncture, low-level laser therapy, and an overview of systematic reviews of 
224 interventions) were withdrawn before the reviews were conducted or completed (Li et al., 
225 2016; Maldonado Fernández et al., 2015; Peng et al., 2014). The protocol for 
226 neurophysiological-based treatments for tinnitus (Phillips and McFerran, 2010b) planned to 
227 include unmodified and modified TRT, meaning it would constitute an update to the TRT 
228 review. However, progress on this new review has been suspended at the suggestion of 
229 Cochrane. Methods in this protocol were judged as needing updating.
230 Eight of the 10 published Cochrane reviews were assessed as having outdated methods by the 
231 Cochrane methodologist (EA). The review of zinc supplementation was judged as up-to-date 
232 and the methods robust (Person et al., 2016). The review of amplification with hearing aids 
233 was judged to have up-to-date methods such that the decision to update would depend on 
234 whether additional RCTs were identified. The number of records included in each of the 10 
235 Cochrane reviews was between one and eight.   
236
237 New trials for potential inclusion in Cochrane reviews
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238 Scoping searches identified 1080 records (Figure 1). Based on title/abstract screening 731 
239 records were selected for full text screening by at least one author. A further 318 records 
240 were excluded that were duplicates (n=127), out of scope (n=11), not randomised (n=86), 
241 conference abstracts with no results published (n=70), or required translation for which we 
242 did not have the resources (Chinese, Japanese, Swedish, Spanish; n=15). Nine abstracts/full 
243 texts were not available. An additional 24 records were identified from lists of references of 
244 systematic reviews bringing the total number of records for full text screening and data 
245 charting to 437. Among those, 365 records were identified that were new (not covered in 
246 existing Cochrane reviews) RCTs with published results: PICOS data were extracted from 
247 those records. In addition, 51 unpublished registered randomised trials were identified and 
248 data regarding PICOS and trial status were extracted. 
249
250 *** INSERT FIGURE 1 ABOUT HERE***
251
252 Education and information
253 Eight trials were identified that examined information or education. 
254 Sound-based interventions
255 Forty-three new trials of sound-based interventions were identified. The interventions trialled 
256 included: 1) Amplification only devices (n=8); 2) Sound generator only devices (sometimes 
257 referred to as maskers; n=20); 3) Combination devices (i.e. combined amplification and 
258 sound generators; n=5); 4) Acoustic Coordinated Reset (CR) Neuromodulation (n=3); 5) 
259 Phase-tailored sound treatment (n=1); 6) Spectrally tailored sound treatment (n=2); and 7) 
260 Auditory training (n=4). 
261 Psychology-based interventions
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262 Thirty-nine new trials of psychology-based intervention were identified. Thirty-three of those 
263 trialled CBT interventions and three trialled counselling. For the purpose of this scoping 
264 review we included all studies using cognitive and/or behavioural approaches to treatment. It 
265 is worth noting that there is a published protocol for a revision of the Cochrane review of 
266 CBT for tinnitus (Fuller et al., 2017a). This review will examine all interventions for tinnitus 
267 that include cognitive, and/or behavioural interventions. Those would include Acceptance 
268 and Commitment Therapy (ACT) and Mindfulness-based therapies, described as different 
269 ‘waves’ of CBT.
270 Self-help interventions
271 One trial was identified that examined a self-help intervention, namely an online discussion 
272 forum. 
273 Relaxation therapy
274 Eighteen trials of relaxation therapy were identified including: Neurofeedback/Biofeedback 
275 (n=8); Hypnosis/Hypnotherapy (n=3); 3) Relaxation (n=7). 
276 Pharmacology-based interventions
277 One hundred and fifty-eight new trials of pharmacological interventions for tinnitus were 
278 identified. They were classified in nine different categories based on the WHO ATC system: 
279 1) Alimentary tract and metabolism (n=12); 2) Blood and blood forming organs (n=8); 3) 
280 Cardiovascular system (n=20); 4) Genito-urinary system and sex hormones (n=5); 5) 
281 Musculo-skeletal system (n=3); 6) Nervous system (n=83); 7) Respiratory system (n=1); 8) 
282 Systemic hormonal preparations, excluding sex hormones and insulins (n=8); and 9) Various 
283 (n=2). Thirteen trials of non-classified (i.e. experimental) medications were also identified. 
284 Manual physical therapy
Page 39 of 58
E-mail:editor.ija@up.ac.za  URL: http://mc.manuscriptcentral.com/tija





























































For Peer Review Only
13
Sereda et al. Prioritising topics for systematic review
13
285 Five trials of manual physical therapy were identified including: 1) Cervical spine treatment 
286 (n=3); 2) Myofascial trigger point deactivation (n=1); and 3) Temporomandibular Joint 
287 Treatment (n=1). 
288 Magnetic stimulation
289 Forty-one trials of magnetic stimulation were identified: 1) Repetitive Transcranial Magnetic 
290 Stimulation (rTMS, n=36), 2) Continuous Theta Burst Stimulation (cTBS, n=2); 3) Deep 
291 Transcranial Magnetic Stimulation (n=1); 4) Electromagnetic Ear Stimulation (n=1); and 5) 
292 Rare-earth magnets placed close to the tympanic membrane (n=1). 
293 Electrical stimulation
294 Twenty-three new trials of electrical stimulation were identified including: 1) Cochlear 
295 implant (n=3); 2) Transcranial Alternating Current Stimulation (tACS; n=1); 3) Transcranial 
296 Direct Current Stimulation (tDCS; n=11); 4) Vagus Nerve Stimulation (VNS; n=3); 5) 
297 Transcutaneous Electrical Nerve Stimulation (TENS; n=2); 6) Ear electrical stimulation via 
298 surface tympanic electrode (n=1); and 7) External electrical stimulation via mastoid bones 
299 (n=1). According to the published Cochrane protocol of neuromodulation 
300 (desynchronisation) for tinnitus (Hoare et al., 2015), all trials of electrical stimulation for 
301 tinnitus are likely to be included.
302 Complementary and alternative therapies
303 Fifty-six trials of complementary and alternative therapies were identified including: 1) 
304 Acupuncture (n=26); 2) Dietary supplements and herbal remedies (n=10); 3) Laser treatment 
305 (n=14); 4) Ozone (n=1); 5) Ultrasound (n=2); 6) Vibratory stimulation (n=2); and 7) Virtual 
306 reality (n=1). 
307 Complex interventions
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308 Twenty-four trials of complex interventions were identified including: 1) Heidelberg Neuro-
309 Music Therapy (n=2); 2) Perceptual/cognitive training (n=4); 3) Progressive Tinnitus 
310 Management (PTM, n=4); 4) Tinnitus Retraining Therapy (TRT, including modified TRT; 
311 n=9); 5) Combination of psychological approaches with other management strategies (n=3); 
312 6) bimodal treatment involving TRT with EMDR and TRT with CBT (n=1); and 7) a 
313 combination of sound based, educational and integrated medicine therapies (n=1).
314 Priority reviews on tinnitus
315 Three high priority reviews were identified based on the pre-defined priority criteria. Those 
316 were: 1) sound therapy using amplification devices and/or sound generators for tinnitus; 2) 
317 betahistine; 3) CBT. 
318 Sound therapy met the first three primary priority criteria, the existing Cochrane reviews 
319 concluded a lack of evidence of clinical eff ctiveness (Hoare et al., 2014a, Hobson et al., 
320 2012) and new trials were identified. Our recommendation was that a priority Cochrane 
321 review should include amplification only devices, combination devices (combined 
322 amplification and sound generation), and sound generators. Suggested comparisons for 
323 inclusion were: 1) Amplification only vs waiting-list control, placebo, education/information 
324 only with no device; 2) Combination devices vs waiting-list control, placebo, 
325 education/information only with no device, amplification only, sound generator only; 3) 
326 Sound generator only vs waiting-list control, placebo, education/information only with no 
327 device. Trials that have conditions that explicitly included counselling (such as TRT, PTM, 
328 Neuromonics) should be excluded. Counselling was defined according to Culley and Bond 
329 (2011) as a process that aims to empower patients to reach decisions and take actions for 
330 themselves. Establishing a therapeutic relationship, clarifying and defining problems, 
331 planning actions, and managing expectations are all key features of the approach. Education 
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332 and information giving can be entirely one-way, whereas counselling is about empowerment 
333 and enabling patients to arrive at their own solutions using their own internal resources. 
334 Therefore, unless there were explicit efforts and description of a process towards 
335 empowerment in trial reports, and a trained therapist delivered it, then it was not considered 
336 counselling.
337 Betahistine also met the first three primary priority criteria and there is no existing Cochrane 
338 review. We identified six trials for consideration. Comparisons should include placebo, no 
339 intervention, education and information only.  However, it should be noted that only three 
340 trials include the above comparisons (n=3) and the others would not be suitable for synthesis. 
341 Subgroup analyses with and without Ménière’s disease should also be considered, but we 
342 note that there is an existing Cochrane review on Betahistine for Ménière’s disease or 
343 syndrome which has impact on tinnitus symptom severity as a secondary outcome (Van Esch 
344 et al., 2018). 
345 CBT met the first three primary priority criteria. Although there is an existing Cochrane 
346 review (Martinez-Devesa et al., 2010) it is now outdated and does not include all cognitive, 
347 and/or behavioural interventions (Acceptance and Commitment Therapy (ACT) and 
348 Mindfulness-based therapies, described as different ‘waves’ of CBT).  A Cochrane review 
349 examining all cognitive and behavioural approaches for tinnitus is currently ongoing (Fuller 
350 et al., 2017b). 
351 Further priorities (meeting fewer priority criteria) included: 1) Gingko biloba; 2) anxiolytics; 
352 3) hypnotics; 4) antiepileptics; 5) neuromodulation.
353 Gingko biloba met the first two primary priority criteria. The existing Cochrane review 
354 concluded a lack of evidence for effectiveness (Hilton et al., 2013) and new trials were 
355 identified. Suggested comparisons include placebo, no intervention, education and 
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356 information only. Anxiolytics met the first two primary criteria and there is no existing 
357 Cochrane review. Nine trials have been identified which may be eligible. Suggested 
358 comparisons are placebo, no intervention, education and information only. Hypnotics meets 
359 the first two primary criteria and there is no existing Cochrane review. Eight trials have been 
360 identified which may be eligible for inclusion. Suggested comparisons are placebo, no 
361 intervention, education and information only. Antiepileptics met the first two primary criteria 
362 and there is no existing Cochrane review. Eleven trials have been identified. Suggested 
363 comparisons include placebo, no intervention, education and information only. 
364 Neuromodulation met two primary criteria including being in scope of the NICE guidelines. 
365 However, a Cochrane review of neuromodulation for tinnitus is currently ongoing (Hoare et 




370 This technical report highlights a comprehensive exercise we undertook to prioritise topics of 
371 unmet need for high-quality systematic review in tinnitus management.
372 Importantly, these priority reviews will respond to unanswered questions identified in current 
373 and developing clinical practice guidelines for tinnitus. Three high priority reviews are 
374 recommended: 1) sound therapy using amplification devices and/or sound generators for 
375 tinnitus; 2) betahistine; 3) Cognitive Behaviour Therapy. Further priorities are: 4) Gingko 
376 biloba; 5) anxiolytics; 6) hypnotics; 7) antiepileptics; 8) neuromodulation.
377 Applying a prioritisation process ensures that resources are invested most effectively in work 
378 that meets the needs of funders and stakeholders and addresses known discrepancies or gaps 
379 in clinical knowledge. This particular prioritisation work focused on UK clinical practice for 
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380 tinnitus and therefore the relevant priority criteria, such as availability of the intervention 
381 within the NHS and inclusion in the scope of the NICE tinnitus guideline. However, the 
382 process can easily be adapted to a range of international, national or local settings and 
383 priorities. For example, regional or country-specific clinical practice can be taken into 
384 consideration as well as guidelines at the national, regional or international level (e.g. 
385 European or country-specific) when formulating the priority criteria. 
386 The scoping exercise described here has already resulted in the expedited production of two 
387 Cochrane systematic reviews (Sereda et al., 2018; Wegner et al., 2018) in part to inform the 
388 NICE guideline on tinnitus which is currently under development. A further three priority 
389 reviews are currently in progress (Fuller et al., 2017b; Hoare et al. 2015; and Gingko biloba – 
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 Supplemental material 1: Summary of priority criteria for each of the interventions
Summary of interventions with ratings according to the primary and secondary criteria for prioritisation. To aid prioritisation decisions, four primary criteria were 
considered: 1. Whether the intervention is available for tinnitus management within the NHS; 2. Whether the intervention is within the scope of the NICE 
tinnitus guidelines that are currently in development; 3. Whether there was ‘no recommendation’ or disagreement in recommendations across current 
management guidelines; and 4. Whether existing Cochrane systematic reviews concluded there was a lack of evidence, but new RCTs are now available or 
there is no Cochrane review.
In addition, four secondary criteria considered: 5. Whether the intervention has been prioritised in the James Lind Alliance Priority Setting Partnership for 
tinnitus as a ‘top 10’ uncertainty; 6. The number of new RCTS identified; 7. Whether interventions are referred to in the TINNET European clinical practice 
guideline; and 8. Whether there is evidence for variability in clinical practice, within or across countries. 



















Pharmacological approaches - Alimentary tract and metabolism
Drugs for functional gastrointestinal disorders NO NO YES YES YES 4 NO YES 
Antiemetics and antinauseants YES NO YES YES YES 1 NO YES
Vitamins – Ascorbic acid (Vitamin C) NO NO YES YES YES 1 YES YES
Vitamins – other plain Vitamin preparations NO NO YES YES YES 2 YES YES
Vitamins – Vitamin B-complex, including 
combinations
NO NO YES YES YES 2 YES YES
Mineral supplements – Zinc NO NO YES NO YES 0 YES YES
Mineral supplements – Magnesium NO NO YES YES YES 1 YES YES
Pharmacological approaches - Blood and blood forming organs
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Antithrombotic agents YES NO YES YES YES 5 NO YES




Pharmacological approaches - Cardiovascular system
Antiarrhytmics YES NO YES YES YES 11 NO YES
Peripheral vasodilators YES NO YES YES YES 5 NO YES
Lipid modifying agents NO NO YES YES YES 1 NO YES
Other cardiac preparations YES NO YES YES YES 3 NO YES
Pharmacological approaches - Genito-urinary system and sex hormones
Uterotonics NO NO YES YES YES 3 NO YES
Urologicals NO NO YES YES YES 2 NO YES
Pharmacological approaches - Musculo-skeletal system
Anti-inflammatory and antirheumatic 
products
YES NO YES YES YES 1 NO YES
Muscle relaxants NO NO YES YES YES 1 NO YES
Pharmacological approaches – Nervous system
Anesthetics - General anesthetics NO NO YES YES YES 4 NO YES
Anesthetics - Local anesthetics YES NO YES YES YES 18 NO YES




Anti-Parkinson drugs YES NO YES YES YES 2 NO YES
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Psycholeptics - Antipsychotics YES NO YES YES YES 2 NO YES
Psycholeptics - Anxiolytics YES NO YES YES YES 8 NO YES





Psychoanaleptics - Antidepressants YES NO YES YES YES 4 YES YES
Psychostimulants and nootropics YES NO YES YES YES 1 NO YES
Anti-dementia drugs YES NO
Ginkgo 
biloba
YES YES YES 6 YES YES
Other nervous system drugs – Drugs used in 
addictive disorders
NO NO YES YES YES 3 NO YES
Antivertigo preparations YES YES
Betahistine
YES YES YES 11 NO YES
Combinations of medications NO NO YES YES YES 1 NO YES
Pharmacological approaches – respiratory system 
Respiratory stimulants YES NO YES YES YES 1 NO YES
Pharmacological approaches - Systemic hormonal preparations, excluding sex hormones and insulins
Pituitary and hypothalamic hormones and 
analogues
NO NO YES YES YES 1 NO YES
Corticosteroids for systemic use YES NO YES YES YES 10 NO YES
Pharmacological approaches – various
Medical gases - Oxygen YES NO YES YES YES 2 NO YES
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Pharmacological approaches - non-classified medications (i.e. experimental)
Amino-oxyacetic acid NO NO YES YES YES 2 NO YES
Glutamate NO NO YES YES YES 1 NO YES
Neramexane NO NO YES YES YES 6 NO YES
Nerve growth factor NO NO YES YES YES 2 NO YES
Dextran 40 NO NO YES YES YES 1 NO YES
Selurampanel NO NO YES YES YES 1 NO YES
Vestipitant NO NO YES YES YES 1 NO YES
Sound-based interventions
Acoustic CR Neuromodulation NO YES YES YES ? 3 YES YES
Amplification only devices YES YES YES YES YES 8 YES YES
Combination devices (i.e. combined 
amplification and sound generation)
YES YES YES YES YES 5 YES YES
Phase-tailored sound treatment NO NO YES YES NO 1 NO YES
Sound generators only devices (sometimes 
referred to as ‘maskers’)
YES YES YES YES NO 20 YES YES
Spectrally tailored sound treatment NO NO YES YES NO 3 YES YES
Auditory training NO YES YES YES NO 4 NO YES
Psychology-based interventions
Cognitive/Behavioural approaches YES YES NO YES YES 36 YES YES
Counselling YES YES NO YES NO 3 YES YES
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Complex interventions
Heidleberg Neuro-Music Therapy NO NO YES YES NO 2 NO YES
Perceptual/Cognitive training NO NO YES YES NO 4 NO YES
Progressive Tinnitus Management NO YES YES YES NO 4 NO YES
Tinnitus Retraining Therapy NO YES YES YES NO 9 YES YES
Various – CBT plus biofeedback NO NO YES YES NO 2 NO YES
Various - CBT plus TRT (Cima) NO NO YES YES NO 1 NO YES
Magnetic stimulation
Transcranial Magnetic Stimulation NO NO YES YES NO 39 YES YES
Various - electromagnetic stimulation of the 
ear
NO NO YES YES NO 1 NO YES
Various – ear magnets NO NO YES YES NO 1 NO YES
Electrical stimulation
Cochlear implants NO NO YES YES NO 3 YES YES
Transcranial Alternating Current Stimulation 
(tACS)
NO NO YES YES NO 1 YES YES
Transcranial Direct Current Stimulation NO NO YES YES NO 11 YES YES
Transcutaneous electrical stimulation NO NO YES YES NO 2 NO YES
Vagus nerve stimulation NO NO YES YES NO 2 YES YES
Various – electrical stimulation of the ear 
(tympanic membrane) 
NO NO YES YES NO 1 NO YES
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Various – electrical stimulation Via mastoid 
bones
NO NO YES YES NO 1 NO YES
Various – electrical epidural stimulation of the 
cortex
NO NO YES YES NO 1 NO YES
Manual physical therapy
Cervical Spine Treatment YES NO YES YES NO 2 NO YES
Myofascial trigger point deactivation NO NO YES YES NO 1 NO YES
Temporomandibular joint treatment YES NO YES YES NO 1 NO YES
Relaxation or stress management
Biofeedback/ Neurofeedback NO NO YES YES NO 8 NO YES
Hypnosis/ hypnotherapy NO NO YES YES NO 3 NO YES
Relaxation YES NO YES YES NO 7 NO YES
Complementary and alternative therapies
Acupuncture NO NO YES YES YES 26 YES YES
Dietary supplements and herbal remedies – 
Alpha lipoic acid
NO NO YES YES YES 1 YES YES
Dietary supplements and herbal remedies – 
Bu-Zhong-Yi-Qi
NO NO YES YES YES 1 YES YES
Dietary supplements and herbal remedies –
Caffeine
NO NO YES YES YES 1 YES YES
Dietary supplements and herbal remedies – 
Gushen Pian
NO NO YES YES YES 1 YES YES
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Dietary supplements and herbal remedies – 
Hangekobokuto
NO NO YES YES YES 1 YES YES
Dietary supplements and herbal remedies – 
Honeybee larvae
NO NO YES YES YES 2 YES YES
Dietary supplements and herbal remedies – 
Korean Red Ginseng
NO NO YES YES YES 1 YES YES
Dietary supplements and herbal remedies – 
Manganese
NO NO YES YES YES 1 YES YES
Dietary supplements and herbal remedies – 
Homeopathy
NO NO YES YES YES 1 YES YES
Laser treatment NO NO YES YES YES 14 NO YES
Ozone NO NO YES YES YES 1 NO YES
Ultrasound NO NO YES YES YES 2 NO YES
Vibratory stimulation NO NO YES YES YES 2 NO YES
Virtual reality NO NO YES YES YES 1 NO YES
Education and information
Education and information YES YES NO YES NO 8 NO YES
Self-help interventions
Support groups YES YES YES YES NO 1 NO YES
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